Novel indolyl-chalcones target stathmin to induce cancer cell death

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Pharmacology

Background:

• Current therapies for advanced and metastatic cancers face significant challenges.
• Novel therapeutic strategies are urgently needed to improve patient outcomes.

Purpose of the Study:

• To investigate the anti-cancer potential of three novel indoly-chalcones (CITs).
• To elucidate the mechanism of action of these compounds in cancer cells.

Main Methods:

• Synthesis and characterization of novel indoly-chalcones (CITs).
• In vitro evaluation of CITs on prostate and lung cancer cell lines.
• Assessment of microtubule dynamics, cell proliferation, and cell death.
• Investigation of the role of stathmin (STMN1) using siRNA knockdown.
• Analysis of cancer cell invasion using matrigel-coated chambers.

Main Results:

• The lead molecule, CIT-026, induced cell death in prostate and lung cancer cell lines at sub-micromolar concentrations.
• CITs destabilized microtubules, reduced cell proliferation, and induced cell death, partly dependent on stathmin (STMN1) expression.
• Knockdown of STMN1 partially restored cancer cell viability.
• CIT-026 and CIT-223 inhibited cancer cell invasion.
• Mechanistically, CITs inhibited STMN1 phosphorylation, leading to STMN1 accumulation and mitotic catastrophe.

Conclusions:

• Novel indoly-chalcone (CIT) molecules possess significant anti-cancer properties.
• The anti-cancer effects are mediated through microtubule destabilization and inhibition of stathmin (STMN1) phosphorylation, resulting in mitotic catastrophe.
• These findings support the development of CITs as potential therapeutic agents for advanced and metastatic cancers.